Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 49

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 49
---

and sell our products. Our focus will be the community of relevant medical practitioners who are the key specialists in treating the patient
populations for which our product candidates are being developed. We may also enter into distribution and other marketing arrangements
with third parties for any of our product candidates that obtain marketing approval.

We currently do not have marketing and sales management operations
for any of our pharmaceutical products and will rely, at least initially, on third parties for support. The responsibilities of marketing
operations would include developing educational initiatives with respect to approved products and establishing relationships with researchers
and practitioners in relevant fields of medicine. We will reevaluate the sales operations from time to time and may eventually build an
in-house marketing and sales management organization.

Our Management Team 

Members of our management team are not obligated to devote any specific
number of hours to our matters but they intend to devote as much of their time as they, in the exercise of their respective business judgement,
deem necessary to our affairs until we have completed our initial business combination. The amount of time that any member of our management
team will devote in any time period will vary based on whether a target business has been selected for our initial business combination
and the current stage of the business combination process. We do not have an employment agreement with any member of our management team.

We believe our management team’s operating and transaction experience
and relationships with companies will provide us with a substantial number of potential business combination targets. Over the course
of their careers, the members of our management team have developed a broad network of contacts and corporate relationships in the healthcare
and biotechnology industry. This network has grown through the activities of our management team sourcing, acquiring and financing businesses,
our management team’s relationships with sellers, financing sources and target management teams and the experience of our management
team in executing transactions under varying economic and financial market conditions. See “Item 10. Directors, Executive Officers
and Corporate Governance” for a more complete description of our management team’s experience.

Status as a Public Company 

We are an “emerging growth company,” as defined in Section 2(a)
of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the JOBS Act. As such, we are eligible to
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging
growth companies” including, but not limited to, not being required to comply with the independent registered public accounting
firm att